Clinical Trial Update: PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating gemcitabine with or without pitavastatin as the primary therapy for unresectable pancreatic adenocarcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pitavastatin (Pitavastatin)

Snippet

Sponsor: University of California, Irvine | Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic | Phase 1 | Status: RECRUITING